ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation

E Shimshoni, D Yablecovitch, L Baram, I Dotan, I Sagi - Gut, 2015 - gut.bmj.com
IBD, which primarily includes UC and Crohn's disease (CD), is a progressive, chronic and
relapsing condition. This debilitating disease is steadily becoming a worldwide medical …

Zinc finger transcription factor MZF1—a specific regulator of cancer invasion

DM Brix, KK Bundgaard Clemmensen, T Kallunki - Cells, 2020 - mdpi.com
Over 90% of cancer deaths are due to cancer cells metastasizing into other organs. Invasion
is a prerequisite for metastasis formation. Thus, inhibition of invasion can be an efficient way …

ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation

G D'Uva, A Aharonov, M Lauriola, D Kain… - Nature cell …, 2015 - nature.com
The murine neonatal heart can regenerate after injury through cardiomyocyte (CM)
proliferation, although this capacity markedly diminishes after the first week of life …

miRNA551b-3p activates an oncostatin signaling module for the progression of triple-negative breast cancer

D Parashar, A Geethadevi, MR Aure, J Mishra… - Cell reports, 2019 - cell.com
Summary Genomic amplification of 3q26. 2 locus leads to the increased expression of
microRNA 551b-3p (miR551b-3p) in triple-negative breast cancer (TNBC). Our results …

Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma

A Xu, X Chu, S Zhang, J Zheng, D Shi, S Lv, F Li… - BMC cancer, 2022 - Springer
Background The determination of HER2 expression status contributes significantly to HER2-
targeted therapy in breast carcinoma. However, an economical, efficient, and non-invasive …

Peritoneal spread of ovarian cancer harbors therapeutic vulnerabilities regulated by FOXM1 and EGFR/ERBB2 signaling

D Parashar, B Nair, A Geethadevi, J George, A Nair… - Cancer research, 2020 - AACR
Peritoneal spread is the primary mechanism of metastasis of ovarian cancer, and survival of
ovarian cancer cells in the peritoneal cavity as nonadherent spheroids and their adherence …

Computational Modeling of ERBB2-Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors

DC Kirouac, JY Du, J Lahdenranta, R Overland… - Science …, 2013 - science.org
Crosstalk and compensatory circuits within cancer signaling networks limit the activity of
most targeted therapies. For example, altered signaling in the networks activated by the …

Patient-derived ovarian cancer spheroids rely on PI3K-AKT signaling addiction for cancer stemness and chemoresistance

D Parashar, A Geethadevi, S Mittal, LA McAlarnen… - Cancers, 2022 - mdpi.com
Simple Summary Epithelial ovarian cancer (EOC) is the most fatal gynecological cancer with
poor survival rates and high mortality. EOC patients respond to standard platinum-based …

Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours

S Zaffryar-Eilot, D Marshall, T Voloshin… - …, 2013 - academic.oup.com
Abstract Lysyl oxidase-like 2 (LOXL2), a secreted enzyme that catalyzes the cross-linking of
collagen, plays an essential role in developmental angiogenesis. We found that …

The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance

KA Whelan, LP Schwab, SV Karakashev… - Journal of Biological …, 2013 - ASBMB
ERBB2, a receptor tyrosine kinase amplified in breast cancer, is a well established regulator
of tumor growth in vivo and anoikis resistance leading to disruption of architecture in three …